According to the FDA, CI 45410 is not permitted for use in eye products
9-12 Many studies have investigated the role of GLP-1 RAs on the risk of ophthalmic diseases, including diabetic retinopathy (DR), glaucoma, AMD, idiopathic intracranial hypertension (IIH), and nonarteritic anterior ischemic optic neuropathy (NAION)
16% OFF In stock VERIFIED BATCH ACCESS See the independent lab report before you buy
This may include: BPC-157 is not a replacement for medical treatment and should only be used as part of a structured, supervised wellness or recovery plan
In the case of a Wegovy pen, it does not have an option to set a dose, does not extend or increase in length, and is only available in five configurations0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg